Six-month HIV prevention jab for 120 countries by 2027
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
Category : Search result: pharmaceutical pricing
UK Worst in Europe for Drug Prices, Says Eli Lilly
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Gold Prices Surge as Pharma Stocks Face Pressure
Financial markets experienced significant volatility as gold hit record highs while pharmaceutical giant Eli Lilly faced pressure over drug pricing concerns. Get the latest analysis on today's market movements.
Scotland's automatic alcohol price hike to tackle deaths
The Scottish Government announces automatic annual increases to minimum alcohol pricing, intensifying efforts to reduce the nation's devastating alcohol mortality rates.
Trump's Tylenol Gaffe Sends Wall Street into Frenzy
Former President Donald Trump's confusion between Tylenol and hydroxychloroquine during the presidential debate triggers a sharp sell-off in pharmaceutical stocks, with Kenvue shares taking a significant hit.
Vegas Hotels Reject Dynamic Pricing in Lobby Shops
Major Las Vegas resorts are making a bold move against controversial surge pricing by guaranteeing fixed prices on essentials in their lobby stores, offering relief to travellers.
Scotland's Alcohol Deaths Crisis: SNP Policy Branded a Failure
Shocking new figures reveal Scotland's alcohol-related deaths remain critically high, sparking fierce criticism of the SNP's flagship minimum unit pricing policy as public health experts demand urgent review.
Tylenol makers hit back at Trump's vaccine comparison
Pharmaceutical giant Kenvue has issued a stern rebuke to Donald Trump after he suggested the COVID-19 vaccine was comparable to the Tylenol murders, calling the analogy 'irresponsible'.
Chinese Executive Jailed in US Fentanyl Case
A senior Chinese pharmaceutical executive has been sentenced to 15 years in a US prison for conspiring to manufacture and distribute fentanyl, marking a significant victory in the transatlantic fight against the opioid crisis.
NHS Drug Pricing: The Art of the Deal Saving Millions
Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.
New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
NHS Must Reverse Medicines Investment Decline - Minister
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Labour's 'War on Motorists': Pay-Per-Mile Plans Exposed
Exclusive: The Labour Party faces fierce backlash over proposals that could lead to pay-per-mile road pricing, a move critics label a devastating attack on drivers and local communities.
Trump Threatens NHS Drug Pricing: UK Faces US Medicine Costs
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
AstraZeneca Pauses £500m Cambridge HQ Investment
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
Common Meds Linked to Youth Suicide Surge, Study Finds
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
AstraZeneca Pauses £200m Cambridge Research Investment
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Target's Major Pricing Bombshell For UK Shoppers
Exclusive: Target employees are being instructed to implement a major new pricing strategy, leaving UK consumers facing unexpected changes at the checkout. We reveal the details.
Just Eat glitch: Woman gets £40 meal for £3.50
A stunned customer received a gourmet three-course meal worth over £40 for just £3.50 due to a major Just Eat pricing error, exposing a loophole in the food delivery platform's system.
Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
MSD to create 125+ new R&D jobs in London expansion
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
FIFA Under Fire: UK Politician Fights Dynamic Pricing Scandal
Exclusive interview with Zohran Kwame Mamdani on his groundbreaking petition challenging FIFA's controversial ticket pricing strategies that are pricing out genuine football fans.
Trump pressured FDA to fast-track Covid vaccine before election
Exclusive report reveals Donald Trump pressured US health officials to accelerate vaccine approval for political gain ahead of the 2020 election, according to congressional investigation.
Mounjaro KwikPens launch without price reduction
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Congress Grills Pharma Over Child Vaccine-Linked Illnesses
A tense US Congressional hearing investigates a surge in severe neurological illnesses in children following vaccination, as lawmakers demand answers from pharmaceutical executives.
Wegovy Jab Sends Novo Nordisk Shares Soaring Past £400bn
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
Germany seizes illegal Wegovy shipment in Frankfurt
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Teen dies after starting new asthma medication
A 13-year-old girl from Northern Ireland tragically passed away just days after being prescribed a new asthma medication. Her devastated family is now demanding answers from health authorities.
Page 1 of 4